Rankings
▼
Calendar
HOTH Q4 2021 Earnings — Hoth Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
HOTH
Hoth Therapeutics, Inc.
$15M
Q4 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$3M
Net Income
-$3M
EPS (Diluted)
$-3.90
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$4M
Free Cash Flow
-$4M
Stock-Based Comp.
$125,991
Balance Sheet
Total Assets
$11M
Total Liabilities
$1M
Stockholders' Equity
$10M
Cash & Equivalents
$9M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$3M
-$802,876
-321.0%
Net Income
-$3M
-$756,787
-359.9%
← FY 2021
All Quarters
Q1 2022 →